Germline IKAROS mutation associated with primary immunodeficiency that progressed to T-cell acute lymphoblastic leukemia

被引：41

作者：

Yoshida, N. ^{[1
]}

Sakaguchi, H. ^{[1
,2
]}

Muramatsu, H. ^{[2
]}

Okuno, Y. ^{[2
,3
]}

Song, C. ^{[4
]}

Dovat, S. ^{[4
]}

Shimada, A. ^{[2
]}

Ozeki, M. ^{[5
]}

Ohnishi, H. ^{[5
]}

Teramoto, T. ^{[5
]}

Fukao, T. ^{[5
]}

Kondo, N. ^{[5
]}

Takahashi, Y. ^{[2
]}

Matsumoto, K. ^{[1
]}

Kato, K. ^{[1
]}

Kojima, S. ^{[2
]}

机构：

[1] Japanese Red Cross Nagoya First Hosp, Dept Hematol & Oncol, Childrens Med Ctr, Nagoya, Aichi, Japan

[2] Nagoya Univ, Dept Pediat, Grad Sch Med, Nagoya, Aichi, Japan

[3] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan

[4] Penn State Univ, Coll Med, Dept Pediat, Div Hematol Oncol, Hershey, PA USA

[5] Gifu Univ, Dept Pediat, Grad Sch Med, Gifu, Japan

来源：

LEUKEMIA | 2017年 / 31卷 / 05期

关键词：

GENE; MICE; NOTCH1; EVENT;

D O I：

10.1038/leu.2017.25

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1221 / 1223

页数：3

共 50 条

[31] JAK1 mutation analysis in T-cell acute lymphoblastic leukemia cell lines
Porcu, Michael
Gielen, Olga
Cools, Jan
De Keersmaecker, Kim
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (03): : 435 - 437
[32] Negative prognostic impact of PTEN mutation in pediatric T-cell acute lymphoblastic leukemia
P Y Jotta
M A Ganazza
A Silva
M B Viana
M J da Silva
L J G Zambaldi
J T Barata
S R Brandalise
J A Yunes
Leukemia, 2010, 24 : 239 - 242
[33] NOVEL DYNAMIN2 MUTATION IN ADULT T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Ge, Z.
Li, M.
Zhao, G.
Jin, N.
Chen, B.
Yu, M. D.
Li, J.
Dovat, S.
Song, C.
HAEMATOLOGICA, 2016, 101 : 356 - 357
[34] Negative prognostic impact of PTEN mutation in pediatric T-cell acute lymphoblastic leukemia
Jotta, P. Y.
Ganazza, M. A.
Silva, A.
Viana, M. B.
da Silva, M. J.
Zambaldi, L. J. G.
Barata, J. T.
Brandalise, S. R.
Yunes, J. A.
LEUKEMIA, 2010, 24 (01) : 239 - 242
[35] Nonsense MED12 mutation in a patient with T-cell acute lymphoblastic leukemia
Heikkinen, Tuomas
Kampjarvi, Kati
Keskitalo, Salla
Turunen, Mikko
Kuusanmaki, Heikki
Makinen, Netta
Mustjoki, Satu
Heckman, Caroline
Varjosalo, Markku
Vahteristo, Pia
CANCER RESEARCH, 2015, 75
[36] TARGETED THERAPY USE IN RARE MUTATION IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
Losole, Taylor
Raulji, Chittalsinh
Patel, Sachit
PEDIATRIC BLOOD & CANCER, 2021, 68 : S146 - S146
[37] P53 MUTATION IN ACUTE T-CELL LYMPHOBLASTIC-LEUKEMIA IS OF SOMATIC ORIGIN AND IS STABLE DURING ESTABLISHMENT OF T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA CELL-LINES
YEARGIN, J
CHENG, J
YU, AL
GJERSET, R
BOGART, M
HAAS, M
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (05): : 2111 - 2117
[38] Transcriptional control of signaling pathways in T-cell lymphoblastic leukemia by Ikaros tumor suppressor
Hu, Tommy
Soliman, Mario
Kapadia, Malika
Dovat, Elanora
Payne, Jonathan
Song, Chunhua
Dovat, Sinisa
CANCER RESEARCH, 2017, 77
[39] Adoptive Cell Therapy for Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia
Lulla, Premal D.
Mamonkin, Maksim
Brenner, Malcolm K.
CANCER JOURNAL, 2019, 25 (03): : 199 - 207
[40] The Genetics and Mechanisms of T-Cell Acute Lymphoblastic Leukemia
Gianni, Francesca
Belver, Laura
Ferrando, Adolfo
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2020, 10 (03):

← 1 2 3 4 5 →